@article{TLCR629,
author = {Rakesh Bagai and Nathan A. Pennell},
title = {ZEPHYR illustrates the perils of testing targeted treatments in unselected non-small-cell lung cancer patients},
journal = {Translational Lung Cancer Research},
volume = {2},
number = {1},
year = {2012},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases and remains the leading cause of cancer-related death. Our understanding of the nature and biology of lung cancer continues to increase as does the notion that NSCLC does not represent a single disease entity, but rather is a collection of diseases with different histologic and genetic subtypes.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/629}
}